InvestorsHub Logo
Followers 130
Posts 14996
Boards Moderated 1
Alias Born 06/04/2018

Re: None

Tuesday, 05/14/2019 10:40:59 AM

Tuesday, May 14, 2019 10:40:59 AM

Post# of 303
News: $HOTH Hoth Therapeutics Signs Term Sheet with Zylö Therapeutics to Acquire a License and Jointly Develop a Product to Treat Lupus

NEW YORK , May 14, 2019 /PRNewswire/ -- Hoth Therapeutics, Inc. (Nasdaq: HOTH) a biopharmaceutical company focused on unique targeted therapeutics for patients suffering from indications such as atopic dermatitis–also known as eczema–as well as dermatological and chroni...

Find out more https://marketwirenews.com/news-releases/hoth-therapeutics-signs-term-sheet-with-zyl-xf6-therapeutics-to-acquire-a-license-and-jointly-develop-a-product-to-treat-lupus-8180890.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent HOTH News